Overdiagnosis or overtreatment? Move to lung cancer screening fuels debate

A report from HLM on Siemens-sponsored, Atlantic-hosted event on "The Diagnostic Debate." Gregory Sorensen, the CEO of Siemens Healthcare North America opened the session by challenging the notion that screening drives overdiagnosis. "We're not over diagnosing," he said. "We're over treating." Sorensen used as an example, mammography. When doctors find a "low-grade" tumor like DCIS … Continue reading Overdiagnosis or overtreatment? Move to lung cancer screening fuels debate